GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Cyclically Adjusted PB Ratio

Terumo (Terumo) Cyclically Adjusted PB Ratio : 4.64 (As of Jun. 10, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Terumo Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Terumo's current share price is $17.16. Terumo's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.70. Terumo's Cyclically Adjusted PB Ratio for today is 4.64.

The historical rank and industry rank for Terumo's Cyclically Adjusted PB Ratio or its related term are showing as below:

TRUMY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.57   Med: 4.88   Max: 7.1
Current: 4.95

During the past years, Terumo's highest Cyclically Adjusted PB Ratio was 7.10. The lowest was 3.57. And the median was 4.88.

TRUMY's Cyclically Adjusted PB Ratio is ranked worse than
78.95% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs TRUMY: 4.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Terumo's adjusted book value per share data for the three months ended in Mar. 2024 was $5.966. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Terumo Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Terumo's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted PB Ratio Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.30 5.26 4.41 3.69 4.97

Terumo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 4.57 3.84 4.36 4.97

Competitive Comparison of Terumo's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PB Ratio falls into.



Terumo Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Terumo's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=17.16/3.7
=4.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Terumo's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.966/107.2000*107.2000
=5.966

Current CPI (Mar. 2024) = 107.2000.

Terumo Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.204 98.000 3.505
201409 3.286 98.500 3.576
201412 3.193 97.900 3.496
201503 3.144 97.900 3.443
201506 3.138 98.400 3.419
201509 3.171 98.500 3.451
201512 3.207 98.100 3.504
201603 3.119 97.900 3.415
201606 3.104 98.100 3.392
201609 3.234 98.000 3.538
201612 3.211 98.400 3.498
201703 3.091 98.100 3.378
201706 3.224 98.500 3.509
201709 3.384 98.800 3.672
201712 3.483 99.400 3.756
201803 3.668 99.200 3.964
201806 3.843 99.200 4.153
201809 4.275 99.900 4.587
201812 4.235 99.700 4.554
201903 4.227 99.700 4.545
201906 4.305 99.800 4.624
201909 4.498 100.100 4.817
201912 4.635 100.500 4.944
202003 4.660 100.300 4.981
202006 4.683 99.900 5.025
202009 4.843 99.900 5.197
202012 4.972 99.300 5.368
202103 5.212 99.900 5.593
202106 5.250 99.500 5.656
202109 5.427 100.100 5.812
202112 5.438 100.100 5.824
202203 5.644 101.100 5.985
202206 5.510 101.800 5.802
202209 5.426 103.100 5.642
202212 5.344 104.100 5.503
202303 5.582 104.400 5.732
202306 5.713 105.200 5.822
202309 5.727 106.200 5.781
202312 5.683 106.800 5.704
202403 5.966 107.200 5.966

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Terumo  (OTCPK:TRUMY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Terumo Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (Terumo) Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.